See more : ProAssurance Corporation (PRA) Income Statement Analysis – Financial Results
Complete financial analysis of Provexis plc (PXS.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Provexis plc, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- GeneLink, Inc. (GNLKQ) Income Statement Analysis – Financial Results
- SHRI VASUPRADA PLANTATIONS LIM (VASUPRADA.BO) Income Statement Analysis – Financial Results
- Zhejiang Taifu Pump Co., Ltd (300992.SZ) Income Statement Analysis – Financial Results
- JCK Hospitality Public Company Limited (JCKH.BK) Income Statement Analysis – Financial Results
- Formuepleje Globale Aktier – Akkumulerende (FPIGAA.CO) Income Statement Analysis – Financial Results
Provexis plc (PXS.L)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.provexis.com
About Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 801.96K | 389.92K | 426.17K | 505.33K | 347.94K | 322.19K | 235.80K | 227.62K | 91.65K | 38.22K | 3.97K | 5.56M | 3.48M | 50.00K | 15.00K | 5.00K | 162.00K | 67.00K | 268.00K | 310.00K | 75.00K |
| Cost of Revenue | 518.17K | 95.50K | 46.12K | 49.14K | 35.78K | 49.43K | 23.17K | 9.53K | 0.00 | 0.00 | 0.00 | 2.42M | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 176.00K | 470.00K | 52.00K |
| Gross Profit | 283.80K | 294.42K | 380.05K | 456.19K | 312.16K | 272.76K | 212.64K | 218.09K | 91.65K | 38.22K | 3.97K | 3.14M | 1.76M | 50.00K | 15.00K | 5.00K | 162.00K | 67.00K | 92.00K | -160.00K | 23.00K |
| Gross Profit Ratio | 35.39% | 75.51% | 89.18% | 90.28% | 89.72% | 84.66% | 90.18% | 95.81% | 100.00% | 100.00% | 100.00% | 56.50% | 50.55% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 34.33% | -51.61% | 30.67% |
| Research & Development | 301.72K | 237.22K | 249.69K | 303.90K | 251.87K | 229.88K | 181.92K | 187.16K | 192.24K | 180.50K | 142.99K | 475.55K | 761.00K | 1.25M | 698.00K | 635.00K | 517.00K | 340.00K | 394.00K | 0.00 | 0.00 |
| General & Administrative | 398.91K | 426.52K | 384.29K | 465.52K | 455.95K | 557.96K | 489.78K | 446.01K | 354.89K | 355.96K | 879.96K | 7.32M | 1.86M | 1.12M | 1.06M | 847.00K | 911.00K | 1.23M | 2.95M | 1.92M | 883.00K |
| Selling & Marketing | 65.71K | 51.61K | 45.27K | 48.69K | 40.66K | 35.03K | 23.88K | 11.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.00K | 31.00K | 0.00 |
| SG&A | 464.61K | 494.76K | 426.57K | 504.10K | 500.65K | 592.99K | 513.66K | 457.34K | 354.89K | 355.96K | 879.96K | 7.32M | 1.86M | 1.12M | 1.06M | 847.00K | 911.00K | 1.23M | 2.98M | 1.95M | 883.00K |
| Other Expenses | 121.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84M | 150.00K | 44.00K | 100.00K | -58.00K | -16.00K | -209.00K | 31.00K | -5.00K |
| Operating Expenses | 887.39K | 731.98K | 676.26K | 808.00K | 752.52K | 806.66K | 680.56K | 630.06K | 547.13K | 536.46K | 1.02M | 7.80M | 4.94M | 2.53M | 1.80M | 1.58M | 1.37M | 1.56M | 3.53M | 1.98M | 883.00K |
| Cost & Expenses | 1.41M | 827.48K | 722.38K | 857.14K | 788.30K | 856.09K | 703.73K | 639.59K | 547.13K | 536.46K | 1.02M | 10.22M | 6.66M | 2.53M | 1.80M | 1.58M | 1.37M | 1.56M | 3.70M | 2.45M | 935.00K |
| Interest Income | 1.59K | 1.01K | 73.00 | 113.00 | 347.00 | 528.00 | 497.00 | 890.00 | 2.77K | 5.08K | 4.89K | 12.41K | 46.00K | 133.00K | 85.00K | 65.00K | 57.00K | 28.00K | 114.00K | 35.00K | 6.00K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.28K | 42.00K | 37.00K | 0.00 | 10.00K | 1.00K | 90.00K | 6.00K | 20.00K | 1.00K |
| Depreciation & Amortization | 0.00 | 420.93K | 299.21K | 361.92K | 424.81K | 533.90K | 467.93K | 411.98K | 455.48K | 9.14K | 9.14K | 3.26M | 1.48M | 29.00K | 21.00K | 21.00K | 15.00K | 4.00K | 380.00K | 8.00K | 4.00K |
| EBITDA | -603.59K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -489.10K | -1.01M | -1.45M | -2.80M | -2.31M | -1.77M | -4.59M | -1.14M | -1.46M | -3.09M | -1.80M | -849.53K |
| EBITDA Ratio | -75.26% | -112.22% | -69.51% | -69.62% | -126.56% | 6.48% | 8.40% | 14.01% | 63.16% | -1,279.55% | -25,455.91% | -24.97% | -47.61% | -4,626.00% | -11,213.33% | -29,820.00% | -701.23% | -2,174.63% | 177.24% | -343.23% | -1,133.33% |
| Operating Income | -603.59K | -437.56K | -296.22K | -351.81K | -440.36K | -533.90K | -467.93K | -411.98K | -455.48K | -498.24K | -1.02M | -4.66M | -4.33M | -2.48M | -1.79M | -4.68M | -1.21M | -1.49M | -172.00K | -1.11M | -860.00K |
| Operating Income Ratio | -75.26% | -112.22% | -69.51% | -69.62% | -126.56% | -165.71% | -198.44% | -180.99% | -496.98% | -1,303.47% | -25,686.31% | -83.76% | -124.50% | -4,950.00% | -11,920.00% | -93,520.00% | -745.68% | -2,222.39% | -64.18% | -357.10% | -1,146.67% |
| Total Other Income/Expenses | 1.59K | 1.01K | 73.00 | 113.00 | -11.16K | 528.00 | 497.00 | 890.00 | 2.77K | 5.08K | 4.89K | 12.41K | 46.11K | 133.00K | 85.00K | -3.02M | 56.00K | -62.00K | 107.88K | 14.55K | 5.00K |
| Income Before Tax | -602.00K | -419.92K | -299.13K | -361.80K | -435.97K | -533.38K | -467.43K | -411.09K | -452.71K | -493.16K | -1.01M | -4.65M | -4.28M | -2.34M | -1.70M | -4.62M | -1.15M | -1.55M | -64.00K | -1.09M | -855.00K |
| Income Before Tax Ratio | -75.07% | -107.69% | -70.19% | -71.60% | -125.30% | -165.55% | -198.23% | -180.60% | -493.96% | -1,290.18% | -25,563.07% | -83.60% | -123.17% | -4,684.00% | -11,353.33% | -92,420.00% | -711.11% | -2,314.93% | -23.88% | -352.26% | -1,140.00% |
| Income Tax Expense | -13.88K | -32.80K | -58.91K | -2.46K | -11.50K | -16.21K | -15.02K | -14.45K | 11.98K | 5.41K | -15.82K | -255.99K | -329.00K | -221.00K | -55.00K | -50.00K | -134.00K | 915.00K | -264.00K | 35.00K | 6.00K |
| Net Income | -586.24K | -385.24K | -224.25K | -341.01K | -406.23K | -513.03K | -448.11K | -380.09K | -409.57K | -435.60K | 488.35K | -4.34M | -3.87M | -1.98M | -1.65M | -4.57M | -1.19M | -2.44M | -49.00K | -1.09M | -855.00K |
| Net Income Ratio | -73.10% | -98.80% | -52.62% | -67.48% | -116.75% | -159.23% | -190.03% | -166.98% | -446.89% | -1,139.59% | 12,310.39% | -78.04% | -111.36% | -3,968.00% | -10,986.67% | -91,420.00% | -733.95% | -3,638.81% | -18.28% | -352.26% | -1,140.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 | -0.03 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 | -0.03 | -0.03 |
| Weighted Avg Shares Out | 2.22B | 2.22B | 2.21B | 2.10B | 2.01B | 1.93B | 1.85B | 1.71B | 1.63B | 1.57B | 1.66B | 1.50B | 1.40B | 1.16B | 940.61M | 647.24M | 396.88M | 251.72M | 201.05M | 33.34M | 26.82M |
| Weighted Avg Shares Out (Dil) | 2.22B | 2.22B | 2.21B | 2.10B | 2.01B | 1.93B | 1.85B | 1.71B | 1.63B | 1.57B | 1.66B | 1.50B | 1.40B | 1.16B | 940.61M | 647.24M | 396.88M | 251.72M | 201.05M | 33.34M | 26.82M |
Source: https://incomestatements.info
Category: Stock Reports